Is it time for everolimus-based combination in castration-resistant prostate cancer? - Wikidata - awgldk - TriplyDB

Is it time for everolimus-based combination in castration-resistant prostate cancer?

Is it time for everolimus-based combination in castration-resistant prostate cancer?

http://www.wikidata.org/entity/Q48091118

about

Is it time for everolimus-based combination in castration-resistant prostate cancer?

http://www.wikidata.org/entity/Q48091118

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@en

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@nl

type

label

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@en

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@nl

prefLabel

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@en

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@nl

P1433

Q48091118-91157305-A4A0-4D4B-961A-4DE2ED83DCB7

P1476

Q48091118-29394302-CF90-4EE7-BB75-CD6314C2B567

P2093

Q48091118-0B1AE357-A6C0-4BDC-8FCF-5A041ABB0645

Q48091118-6A2CF3E0-4DCE-4A7E-9606-E3FA8ADD1F9B

Q48091118-6E1FC7DF-0591-418E-8F19-371F243410DA

Q48091118-7DD75061-B1B3-449A-BB39-27EFA5AA023F

Q48091118-AF0C4807-1248-4DD7-B7BC-AABA3FD644F0

P2860

Q48091118-1F223D88-5D13-4495-B501-AA0B2099DC79

Q48091118-24F82D11-F44A-4978-B9E7-CCD13DDC686E

Q48091118-280EC18C-932F-410F-B492-DB449E51CCB2

Q48091118-3E54F3F1-9357-4A26-B04F-D35765F026E3

Q48091118-3FD87AC0-9B5E-4EB9-BFC1-5789A9B7DD00

Q48091118-539A3580-EEA7-42A0-A7F7-CCEF93ECCAD4

Q48091118-53B6D48A-B604-4A86-809C-C60ED34EBDC5

Q48091118-565429A6-FE5A-4292-A04D-CF11D85025B7

Q48091118-5C02635A-F91E-4603-B3F5-613979F65C97

Q48091118-8A075F25-CD67-4195-8748-A7D956D9032F

P304

Q48091118-0D87CE57-1DE1-4DBA-9D2E-DA5D12E74422

P31

Q48091118-7ffd9eb7-a767-4cdd-a9d3-8956e55fd51e

Q48091118-965FFF52-9766-43AB-8C3E-EEBC3A9E7571

P356

Q48091118-7FE61B8B-F576-4882-9CCE-43BCF31F1E96

P407

Q48091118-6922CC8F-CBB5-4553-8E8A-9F9A8A535ACF

P433

Q48091118-1434D321-876E-4EA1-9DF7-3D28027DC93D

P478

Q48091118-76DE3CE4-E565-4D05-B432-22634CF1C3EA

P50

Q48091118-4FB2A4F2-F1CB-4D9B-BF26-45FE79E5DDFE

Q48091118-81D07773-E0A2-4FA1-87A8-305F34244A21

P577

Q48091118-8263A920-1399-4080-8965-03656F07E0C7

P698

Q48091118-97BC1F42-3257-4D36-A997-D83B29209E15

P356

P1433

Future Oncology

P1476

Is it time for everolimus-based combination in castration-resistant prostate cancer?

@en

P2093

Alberto Bottini

http://www.w3.org/2001/XMLSchema#string

Andrea Ravelli

http://www.w3.org/2001/XMLSchema#string

Daniele Generali

http://www.w3.org/2001/XMLSchema#string

Fausto Petrelli

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Androgen receptor splice variants determine taxane sensitivity in prostate cancer.

Targeting continued androgen receptor signaling in prostate cancer.

PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.

The third line of treatment for metastatic prostate cancer patients: Option or strategy?

Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol.

P304

1849-1852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0136

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Giandomenico Roviello

P577

2016-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27250597

http://www.w3.org/2001/XMLSchema#string